Live Breaking News & Updates on Nexium Antitrust Litig|Page 1

Stay updated with breaking news from Nexium antitrust litig. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

10 Years after Actavis, the Cases that Follow Tell a Story | Haug Partners LLP

I. Introduction - No pharmaceutical antitrust decision has had more impact than the Supreme Court’s 2013 decision in Federal Trade Commission v. Actavis, a decision which. ....

Rhode Island , United States , New Jersey , Nisha Gera , Lauraann Wood , David Shotlander , Brendan Pierson , Anjali Dhamsania , Ralph Labaton , Epipen Mktg , Justice Roberts , Bonnie Eslinger , Matthew Kelly , Cephalon Inc , District Court Markman , Supreme Court Actavis , Gilead Sciences Inc , Abbvie Inc , Geneva Pharms Inc , Impax Labs Inc , Watson Pharms Inc , Us Court Upholds Astrazeneca , Supreme Court , Warner Chilcott , Valley Drug Co , Eastman Kodak Co ,

Jury Finds Gilead and Teva Did Not Engage in an Anticompetitive Pay-for-Delay Scheme for HIV Drugs | Wilson Sonsini Goodrich & Rosati

On June 30, 2023, a jury in the Northern District of California found Gilead and Teva not liable in a trial accusing the companies of engaging in an illegal reverse payment to delay. ....

United States , Hanna Neill , Opana Erfound , Brendan Coffman , Nathan Mendelsohn , Wilson Sonsini Goodrich Rosati , Drug Administration , Health Care Chron , Wilson Sonsini Goodrich , Northern District , Given Gilead , Nexium Antitrust Litig , Civil Case , Privilege Waiver , Reverse Payment Case , Plaintiffs Based , Health Care , New Trial ,